CLB Quote, Financials, Valuation and Earnings

CKX Lands has a net margin of -0.13% compared to Core Laboratories's net margin of 17.81%. Core Laboratories's return on equity of 11.15% beat CKX Lands's return on equity of 1.36%.

Core Laboratories has a consensus price target of $15.80, signalling upside risk potential of 33.33%. On the other hand CKX Lands has an analysts' consensus of -- which suggests that it could fall by --. Given that Core Laboratories has higher upside potential than CKX Lands, analysts believe Core Laboratories is more attractive than CKX Lands.

Core Laboratories has a beta of 1.446, which suggesting that the stock is 44.586% more volatile than S&P 500. In comparison CKX Lands has a beta of -0.104, suggesting its less volatile than the S&P 500 by 110.442%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.34%. CKX Lands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.98% of its earnings as a dividend. CKX Lands pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are larger than CKX Lands quarterly revenues of $180.6K. Core Laboratories's net income of -$154K is lower than CKX Lands's net income of $32.2K. Notably, Core Laboratories's price-to-earnings ratio is 20.08x while CKX Lands's PE ratio is 102.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.09x versus 15.19x for CKX Lands. Usually stocks with elevated PS ratios are considered overvalued.

Empire Petroleum has a net margin of -0.13% compared to Core Laboratories's net margin of -38.8%. Core Laboratories's return on equity of 11.15% beat Empire Petroleum's return on equity of -56.67%.

Core Laboratories has a consensus price target of $15.80, signalling upside risk potential of 33.33%. On the other hand Empire Petroleum has an analysts' consensus of -- which suggests that it could fall by --. Given that Core Laboratories has higher upside potential than Empire Petroleum, analysts believe Core Laboratories is more attractive than Empire Petroleum.

Core Laboratories has a beta of 1.446, which suggesting that the stock is 44.586% more volatile than S&P 500. In comparison Empire Petroleum has a beta of 1.226, suggesting its more volatile than the S&P 500 by 22.63%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.34%. Empire Petroleum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.98% of its earnings as a dividend. Empire Petroleum pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are larger than Empire Petroleum quarterly revenues of $10.2M. Core Laboratories's net income of -$154K is higher than Empire Petroleum's net income of -$4M. Notably, Core Laboratories's price-to-earnings ratio is 20.08x while Empire Petroleum's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.09x versus 2.34x for Empire Petroleum. Usually stocks with elevated PS ratios are considered overvalued.

Oceaneering International has a net margin of -0.13% compared to Core Laboratories's net margin of 7.47%. Core Laboratories's return on equity of 11.15% beat Oceaneering International's return on equity of 26.18%.

Core Laboratories has a consensus price target of $15.80, signalling upside risk potential of 33.33%. On the other hand Oceaneering International has an analysts' consensus of $20.50 which suggests that it could grow by 4.38%. Given that Core Laboratories has higher upside potential than Oceaneering International, analysts believe Core Laboratories is more attractive than Oceaneering International.

Core Laboratories has a beta of 1.446, which suggesting that the stock is 44.586% more volatile than S&P 500. In comparison Oceaneering International has a beta of 1.538, suggesting its more volatile than the S&P 500 by 53.803%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.34%. Oceaneering International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.98% of its earnings as a dividend. Oceaneering International pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are smaller than Oceaneering International quarterly revenues of $674.5M. Core Laboratories's net income of -$154K is lower than Oceaneering International's net income of $50.4M. Notably, Core Laboratories's price-to-earnings ratio is 20.08x while Oceaneering International's PE ratio is 11.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.09x versus 0.73x for Oceaneering International. Usually stocks with elevated PS ratios are considered overvalued.

Schlumberger has a net margin of -0.13% compared to Core Laboratories's net margin of 9.39%. Core Laboratories's return on equity of 11.15% beat Schlumberger's return on equity of 19.04%.

Core Laboratories has a consensus price target of $15.80, signalling upside risk potential of 33.33%. On the other hand Schlumberger has an analysts' consensus of $47.50 which suggests that it could grow by 32.79%. Given that Core Laboratories has higher upside potential than Schlumberger, analysts believe Core Laboratories is more attractive than Schlumberger.

Core Laboratories has a beta of 1.446, which suggesting that the stock is 44.586% more volatile than S&P 500. In comparison Schlumberger has a beta of 1.056, suggesting its more volatile than the S&P 500 by 5.627%.

Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.34%. Schlumberger offers a yield of 3.1% to investors and pays a quarterly dividend of $0.29 per share. Core Laboratories pays 5.98% of its earnings as a dividend. Schlumberger pays out 34.37% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Core Laboratories quarterly revenues are $123.6M, which are smaller than Schlumberger quarterly revenues of $8.5B. Core Laboratories's net income of -$154K is lower than Schlumberger's net income of $797M. Notably, Core Laboratories's price-to-earnings ratio is 20.08x while Schlumberger's PE ratio is 12.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.09x versus 1.41x for Schlumberger. Usually stocks with elevated PS ratios are considered overvalued.